Skip to content

Minimus I; Minimus III, Sanaphon

by Rud Riester GmbH & CO KG

510(k) K942649

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK942649 Date29 Nov 1994ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXN
Models / Variants
Device Class
Class II
Regulation
21 CFR Part 870.1130
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Minimus I; Minimus III, Sanaphon are aneroid sphygmomanometers designed for measuring blood pressure. These devices fall under the cardiovascular category and are intended for clinical use in assessing arterial blood pressure in patients. The Minimus I and Minimus III models feature a twin-tube design, providing accurate and reliable readings essential for cardiovascular monitoring and diagnosis.

These sphygmomanometers are portable, reusable devices supplied with a metal construction and corrosion-resistant materials. The Minimus III model includes a chromium-plated screwed tube connector and an ergonomic spoon-shaped grip for ease of use. They are classified under FDA product code DXN and have received a Traditional 510(k) clearance under the FDA’s cardiovascular review pathway, with a decision date of November 29, 1994. No specific sterility or MRI safety information is provided in the data.

Other devices from Rud Riester GmbH & CO KG

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Minimus I; Minimus III, Sanaphon used for?

    The Minimus I and Minimus III, Sanaphon are aneroid sphygmomanometers designed specifically for measuring arterial blood pressure in patients. They fall under the cardiovascular category and are intended for clinical use, providing reliable readings essential for cardiovascular monitoring and diagnosis. The twin-tube design ensures precision, making them suitable for routine patient assessments.

  • How is the Minimus III supplied and what materials are used?

    The Minimus III is supplied as a portable, reusable device with a metal construction. It features corrosion-resistant materials for durability and includes a chromium-plated screwed tube connector. The ergonomic spoon-shaped grip enhances ease of use, making it practical for clinical environments where portability and reliability are important.

  • Is the Minimus I or III single-use or reusable?

    Both the Minimus I and Minimus III are reusable devices. They are designed for repeated use in clinical settings, provided they are properly maintained and cleaned according to standard medical device protocols. No specific sterility information is provided, so adherence to facility-specific decontamination procedures is recommended.

  • What distinguishes the Minimus III from the Minimus I?

    The Minimus III includes additional features not mentioned for the Minimus I, such as a chromium-plated screwed tube connector and an ergonomic spoon-shaped grip. While both models share the twin-tube design for accurate blood pressure measurement, the Minimus III’s enhanced grip and connector likely improve usability and longevity in clinical environments.

  • What regulatory pathway was followed for FDA clearance?

    The Minimus I; Minimus III, Sanaphon received a Traditional 510(k) clearance under the FDA’s cardiovascular review pathway. The decision was made by the Cardiovascular (CV) Advisory Committee, and the device was deemed substantially equivalent to a predicate product. The clearance date was November 29, 1994, with the product classified under FDA product code DXN.